Intravesical onabotulinumtoxinA injections in patients on antiplatelet and anticoagulation therapy.

Elsie E Mensah Bogdan Toia Linh NguyenRizwan HamidMahreen PakzadJeremy L OckrimRoger WalkerTamsin J GreenwellTharani NitkunanDavendra SharmaJai H Seth

Published in: Neurourology and urodynamics (2021)

Continuation of AP/AC therapy during intravesical BoNT-A injection treatment appears to be safe-with a 0.88% rate of spontaneously resolving hematuria.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
transcription factor
ultrasound guided
venous thromboembolism
muscle invasive bladder cancer
bone marrow
patient reported outcomes